{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:57:13Z","timestamp":1785243433874,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS098772"],"award-info":[{"award-number":["NS098772"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12035-019-01734-2","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T07:02:56Z","timestamp":1566370976000},"page":"668-684","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin"],"prefix":"10.1007","volume":"57","author":[{"given":"James","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Brustovetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshayalakshmi","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore R.","family":"Cummins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6564-2560","authenticated-orcid":false,"given":"Nickolay","family":"Brustovetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"issue":"5","key":"1734_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57(5):369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1734_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA et al (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"12","key":"1734_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","volume":"31","author":"E Bossy-Wetzel","year":"2008","unstructured":"Bossy-Wetzel E, Petrilli A, Knott AB (2008) Mutant huntingtin and mitochondrial dysfunction. Trends Neurosci 31(12):609\u2013616","journal-title":"Trends Neurosci"},{"key":"1734_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147:358\u2013382","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1734_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","volume":"61","author":"PH Reddy","year":"2009","unstructured":"Reddy PH, Mao P, Manczak M (2009) Mitochondrial structural and functional dynamics in Huntington\u2019s disease. Brain Res Rev 61(1):33\u201348","journal-title":"Brain Res Rev"},{"issue":"1","key":"1734_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","volume":"1802","author":"M Damiano","year":"2010","unstructured":"Damiano M, Galvan L, Deglon N, Brouillet E (2010) Mitochondria in Huntington\u2019s disease. Biochim Biophys Acta 1802(1):52\u201361","journal-title":"Biochim Biophys Acta"},{"issue":"20","key":"1734_CR7","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19(20):3919\u20133935","journal-title":"Hum Mol Genet"},{"issue":"12","key":"1734_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/emmm.201000102","volume":"2","author":"V Costa","year":"2010","unstructured":"Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, Malorni W, Davies KJ et al (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med 2(12):490\u2013503","journal-title":"EMBO Mol Med"},{"issue":"3","key":"1734_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J et al (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17(3):377\u2013382","journal-title":"Nat Med"},{"issue":"7","key":"1734_CR10","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20(7):1438\u20131455","journal-title":"Hum Mol Genet"},{"issue":"18","key":"1734_CR11","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V et al (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24(18):8195\u20138209","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1734_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DT Chang","year":"2006","unstructured":"Chang DT, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22(2):388\u2013400","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1734_CR13","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG et al (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28(11):2783\u20132792","journal-title":"J Neurosci"},{"issue":"2","key":"1734_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Hum Mol Genet 21(2):406\u2013420","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1734_CR15","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s12035-015-9188-0","volume":"53","author":"N Brustovetsky","year":"2016","unstructured":"Brustovetsky N (2016) Mutant huntingtin and elusive defects in oxidative metabolism and mitochondrial calcium handling. Mol Neurobiol 53(5):2944\u20132953","journal-title":"Mol Neurobiol"},{"issue":"17","key":"1734_CR16","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1093\/hmg\/ddv209","volume":"24","author":"J Hamilton","year":"2015","unstructured":"Hamilton J, Pellman JJ, Brustovetsky T, Harris RA, Brustovetsky N (2015) Oxidative metabolism in YAC128 mouse model of Huntington\u2019s disease. Hum Mol Genet 24(17):4862\u20134878","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1734_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/jnc.13165","volume":"134","author":"JJ Pellman","year":"2015","unstructured":"Pellman JJ, Hamilton J, Brustovetsky T, Brustovetsky N (2015) Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington\u2019s disease. J Neurochem 134(4):652\u2013667","journal-title":"J Neurochem"},{"issue":"13","key":"1734_CR18","first-page":"2762","volume":"25","author":"J Hamilton","year":"2016","unstructured":"Hamilton J, Pellman JJ, Brustovetsky T, Harris RA, Brustovetsky N (2016) Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6\/2 mice, a model of Huntington\u2019s disease. Hum Mol Genet 25(13):2762\u20132775","journal-title":"Hum Mol Genet"},{"key":"1734_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuint.2017.01.001","volume":"109","author":"J Hamilton","year":"2017","unstructured":"Hamilton J, Brustovetsky T, Brustovetsky N (2017) Oxidative metabolism and Ca2+ handling in striatal mitochondria from YAC128 mice, a model of Huntington\u2019s disease. Neurochem Int 109:24\u201333","journal-title":"Neurochem Int"},{"issue":"13","key":"1734_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N et al (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12(13):1555\u20131567","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1734_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y et al (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87(3):493\u2013506","journal-title":"Cell"},{"issue":"3","key":"1734_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41593-018-0075-7","volume":"21","author":"MB Victor","year":"2018","unstructured":"Victor MB, Richner M, Olsen HE, Lee SW, Monteys AM, Ma C, Huh CJ, Zhang B et al (2018) Striatal neurons directly converted from Huntington\u2019s disease patient fibroblasts recapitulate age-associated disease phenotypes. Nat Neurosci 21(3):341\u2013352","journal-title":"Nat Neurosci"},{"issue":"2","key":"1734_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, Melov S, Ellerby LM (2012) Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11(2):253\u2013263","journal-title":"Cell Stem Cell"},{"issue":"8","key":"1734_CR24","first-page":"1","volume":"321H","author":"SK Ohlemacher","year":"2015","unstructured":"Ohlemacher SK, Iglesias CL, Sridhar A, Gamm DM, Meyer JS (2015) Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells. Curr Protoc Stem Cell Biol 321H(8):1\u20131H.8.20","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"1","key":"1734_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0003-2697(75)90580-1","volume":"69","author":"GA Kimmich","year":"1975","unstructured":"Kimmich GA, Randles J, Brand JS (1975) Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system. Anal Biochem 69(1):187\u2013206","journal-title":"Anal Biochem"},{"issue":"6","key":"1734_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/cyto.a.21061","volume":"79","author":"C Cottet-Rousselle","year":"2011","unstructured":"Cottet-Rousselle C, Ronot X, Leverve X, Mayol JF (2011) Cytometric assessment of mitochondria using fluorescent probes. Cytometry A 79(6):405\u2013425","journal-title":"Cytometry A"},{"issue":"3","key":"1734_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41418-017-0020-4","volume":"25","author":"NMC Connolly","year":"2018","unstructured":"Connolly NMC, Theurey P, Adam-Vizi V, Bazan NG, Bernardi P, Bolanos JP, Culmsee C, Dawson VL et al (2018) Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases. Cell Death Differ 25(3):542\u2013572","journal-title":"Cell Death Differ"},{"key":"1734_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/B978-0-12-801415-8.00013-8","volume":"547","author":"BM Polster","year":"2014","unstructured":"Polster BM, Nicholls DG, Ge SX, Roelofs BA (2014) Use of potentiometric fluorophores in the measurement of mitochondrial reactive oxygen species. Methods Enzymol 547:225\u2013250","journal-title":"Methods Enzymol"},{"issue":"18","key":"1734_CR29","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1242\/dev.123851","volume":"142","author":"P Kirwan","year":"2015","unstructured":"Kirwan P, Turner-Bridger B, Peter M, Momoh A, Arambepola D, Robinson HP, Livesey FJ (2015) Development and function of human cerebral cortex neural networks from pluripotent stem cells in vitro. Development 142(18):3178\u20133187","journal-title":"Development"},{"issue":"5","key":"1734_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C et al (2008) Disease-specific induced pluripotent stem cells. Cell 134(5):877\u2013886","journal-title":"Cell"},{"key":"1734_CR31","doi-asserted-by":"crossref","unstructured":"Zhang N, An MC, Montoro D, Ellerby LM (2010) Characterization of human Huntington\u2019s disease cell model from induced pluripotent stem cells. PLoS Curr 2RRN1193","DOI":"10.1371\/currents.RRN1193"},{"issue":"1","key":"1734_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","volume":"101","author":"JM Oliveira","year":"2007","unstructured":"Oliveira JM, Jekabsons MB, Chen S, Lin A, Rego AC, Goncalves J, Ellerby LM, Nicholls DG (2007) Mitochondrial dysfunction in Huntington\u2019s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice. J Neurochem 101(1):241\u2013249","journal-title":"J Neurochem"},{"issue":"11","key":"1734_CR33","doi-asserted-by":"publisher","first-page":"e81528","DOI":"10.1371\/journal.pone.0081528","volume":"8","author":"C Gouarne","year":"2013","unstructured":"Gouarne C, Tardif G, Tracz J, Latyszenok V, Michaud M, Clemens LE, Yu-Taeger L, Nguyen HP et al (2013) Early deficits in glycolysis are specific to striatal neurons from a rat model of Huntington disease. PLoS One 8(11):e81528","journal-title":"PLoS One"},{"issue":"3","key":"1734_CR34","doi-asserted-by":"publisher","first-page":"e0152016","DOI":"10.1371\/journal.pone.0152016","volume":"11","author":"SA Mookerjee","year":"2016","unstructured":"Mookerjee SA, Nicholls DG, Brand MD (2016) Determining maximum glycolytic capacity using extracellular flux measurements. PLoS One 11(3):e0152016","journal-title":"PLoS One"},{"key":"1734_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-61779-382-0_8","volume":"810","author":"DG Nicholls","year":"2012","unstructured":"Nicholls DG (2012) Fluorescence measurement of mitochondrial membrane potential changes in cultured cells. Methods Mol Biol 810:119\u2013133","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1734_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2011.12.042","volume":"46","author":"S Camnasio","year":"2012","unstructured":"Camnasio S, Delli CA, Lombardo A, Grad I, Mariotti C, Castucci A, Rozell B, Lo RP et al (2012) The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington\u2019s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol Dis 46(1):41\u201351","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1734_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/BJ20111495","volume":"446","author":"JI Chae","year":"2012","unstructured":"Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y et al (2012) Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington\u2019s disease patient. Biochem J 446(3):359\u2013371","journal-title":"Biochem J"},{"issue":"2","key":"1734_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"VB Mattis","year":"2012","unstructured":"Mattis VB, Svendsen SP, Ebert A, Svendsen CN, King AR, Casale M, Winokur ST, Castiglioni V et al (2012) Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11(2):264\u2013278","journal-title":"Cell Stem Cell"},{"key":"1734_CR39","doi-asserted-by":"publisher","unstructured":"Kedaigle AJ, Fraenkel E, Atwal RS, Wu M, Gusella JF, MacDonald ME, Kaye JA, Finkbeiner S et al (2019) Bioenergetic deficits in Huntington\u2019s disease iPSC-derived neural cells and rescue with glycolytic metabolites. Hum Mol Genet. https:\/\/doi.org\/10.1093\/hmg\/ddy430","DOI":"10.1093\/hmg\/ddy430"},{"issue":"20","key":"1734_CR40","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","volume":"330","author":"B Kremer","year":"1994","unstructured":"Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J, Squitieri F, Lin B et al (1994) A worldwide study of the Huntington\u2019s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 330(20):1401\u20131406","journal-title":"N Engl J Med"},{"issue":"2","key":"1734_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"RH Myers","year":"2004","unstructured":"Myers RH (2004) Huntington\u2019s disease genetics. NeuroRx 1(2):255\u2013262","journal-title":"NeuroRx"},{"issue":"3","key":"1734_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90(3):905\u2013981","journal-title":"Physiol Rev"},{"issue":"6","key":"1734_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD, Ganat YM, Kishinevsky S, Bowman RL, Liu B, Tu EY, Mandal PK, Vera E et al (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13(6):691\u2013705","journal-title":"Cell Stem Cell"},{"key":"1734_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fncel.2013.00037","volume":"7","author":"JC Niclis","year":"2013","unstructured":"Niclis JC, Pinar A, Haynes JM, Alsanie W, Jenny R, Dottori M, Cram DS (2013) Characterization of forebrain neurons derived from late-onset Huntington\u2019s disease human embryonic stem cell lines. Front Cell Neurosci 7:37","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"1734_CR45","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","volume":"145","author":"E Trushina","year":"2007","unstructured":"Trushina E, McMurray CT (2007) Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 145(4):1233\u20131248","journal-title":"Neuroscience"},{"issue":"5","key":"1734_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","volume":"2","author":"Z Xun","year":"2012","unstructured":"Xun Z, Rivera-Sanchez S, Ayala-Pena S, Lim J, Budworth H, Skoda EM, Robbins PD, Niedernhofer LJ et al (2012) Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease. Cell Rep 2(5):1137\u20131142","journal-title":"Cell Rep"},{"issue":"9","key":"1734_CR47","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","volume":"25","author":"X Yin","year":"2016","unstructured":"Yin X, Manczak M, Reddy PH (2016) Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington\u2019s disease. Hum Mol Genet 25(9):1739\u20131753","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1734_CR48","doi-asserted-by":"publisher","first-page":"e0194580","DOI":"10.1371\/journal.pone.0194580","volume":"13","author":"AA Polyzos","year":"2018","unstructured":"Polyzos AA, Wood NI, Williams P, Wipf P, Morton AJ, McMurray CT (2018) XJB-5-131-mediated improvement in physiology and behaviour of the R6\/2 mouse model of Huntington\u2019s disease is age- and sex-dependent. PLoS One 13(4):e0194580","journal-title":"PLoS One"},{"issue":"2","key":"1734_CR49","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1046\/j.1471-4159.2000.0750840.x","volume":"75","author":"ZI Alam","year":"2000","unstructured":"Alam ZI, Halliwell B, Jenner P (2000) No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington\u2019s disease. J Neurochem 75(2):840\u2013846","journal-title":"J Neurochem"},{"key":"1734_CR50","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/j.freeradbiomed.2015.10.087","volume":"87","author":"IV Perevoshchikova","year":"2015","unstructured":"Perevoshchikova IV, Gerencser AA, Brand MD (2015) Lack of oxidative stress in a mouse neural cell stem cell model of Huntington\u2019s disease. Free Radic Biol Med 87:S32","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1734_CR51","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/rej.2015.1736","volume":"19","author":"PS Brocardo","year":"2016","unstructured":"Brocardo PS, McGinnis E, Christie BR, Gil-Mohapel J (2016) Time-course analysis of protein and lipid oxidation in the brains of Yac128 Huntington\u2019s disease transgenic mice. Rejuvenation Res 19(2):140\u2013148","journal-title":"Rejuvenation Res"},{"issue":"9","key":"1734_CR52","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","volume":"25","author":"A Polyzos","year":"2016","unstructured":"Polyzos A, Holt A, Brown C, Cosme C, Wipf P, Gomez-Marin A, Castro MR, Ayala-Pena S et al (2016) Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes. Hum Mol Genet 25(9):1792\u20131802","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1734_CR53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B, Yoon SI, Huang Y, Ooi J, Utami KH, Ziaei A et al (2017) Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep 8(3):619\u2013633","journal-title":"Stem Cell Rep"},{"issue":"Pt A","key":"1734_CR54","first-page":"181","volume":"161","author":"AA Polyzos","year":"2016","unstructured":"Polyzos AA, McMurray CT (2016) The chicken or the egg: mitochondrial dysfunction and oxidative damage as a cause or consequence of toxicity in Huntington\u2019s disease. Mech Ageing Dev 161(Pt A):181\u2013197","journal-title":"Mech Ageing Dev"},{"key":"1734_CR55","doi-asserted-by":"crossref","unstructured":"Polyzos AA, Lee DY, Datta R, Hauser M, Budworth H, Holt A, Mihalik S, Goldschmidt P et al (2019) Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in Huntington mice. Cell Metab 291\u2013216","DOI":"10.1016\/j.cmet.2019.03.004"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-019-01734-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01734-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T12:32:25Z","timestamp":1650457945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-019-01734-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["1734"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01734-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736479025.793593623","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}